Piper Sandler Maintains Overweight on Cargo Therapeutics, Lowers Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Biren Amin maintains an Overweight rating on Cargo Therapeutics (NASDAQ:CRGX) but lowers the price target from $37 to $34.
August 13, 2024 | 11:27 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Piper Sandler maintains an Overweight rating on Cargo Therapeutics but lowers the price target from $37 to $34.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100